The c-fos gene (also known as Fos) is induced by a broad range of stimuli and is a reliable marker for neural activity. Its induction mechanism and available reporter mouse lines are based exclusively on c-fos promoter activity. Here we demonstrate that multiple enhancers surrounding the c-fos gene are crucial for ensuring robust c-fos response to various stimuli. Membrane depolarization, brain-derived neurotrophic factor (BDNF) and forskolin activate distinct subsets of the enhancers to induce c-fos transcription in neurons, suggesting that stimulus-specific combinatorial activation of multiple enhancers underlies the broad inducibility of the c-fos gene. Accordingly, the functional requirement of key transcription factors varies depending on the type of stimulation. Combinatorial enhancer activation also occurs in the brain. Providing a comprehensive picture of the c-fos induction mechanism beyond the minimal promoter, our study should help in understanding the physiological nature of c-fos induction in relation to neural activity and plasticity.
a r t I C l e S Neuronal activity generated spontaneously during the early stages of brain development and through sensory experience throughout life is essential to the development and function of neural circuits. Upon sensory experience, synaptic activity induces rapid calcium influx in postsynaptic neurons, which in turn mediates a multitude of intracellular events necessary for remodeling the synaptic connectivity of the circuit 1 . A calcium rise within the postsynaptic compartments can promptly initiate strengthening or weakening of the synaptic connectivity through local biochemical actions such as mRNA translation, post-translational modifications and trafficking of synaptically localized proteins. In parallel, calcium influx can also induce a cell-wide adaptive response by activating nuclear gene expression through specific calcium-dependent signaling cascades. The timely synthesis and deployment of new gene products mediated by the activity-regulated gene expression program allows sustainable changes in the structures and functions of individual synapses and the resulting behavioral plasticity.
A notable feature of the activity-induced transcription program is the biphasic nature of transcriptional induction. Many immediate early genes (IEGs) that are rapidly induced upon an increase in neural activity encode transcription factors (TFs) such as c-FOS, EGR1 and NR4A1. These TFs can subsequently drive a second wave of transcription of delayed genes, many of which encode products that are localized or act at synapses. Consistent with this biphasic arrangement of the transcription program, transcription inhibitors block long-term synaptic plasticity and behavior in vertebrates only when administered during and/or immediately after stimulation 2 . This result emphasizes the importance of a transcription mechanism that can ensure rapid IEG induction within the narrow temporal window after stimulation. Moreover, the diversity and specificity of the cellular response to different extracellular stimuli are mediated, at least in part, by distinct combinatorial induction of a relatively small number of IEG-encoded TFs 3 . For example, in the rat pheochromocytoma cell line PC12, c-jun (also known as Jun) is induced by growth factors but not by membrane depolarization, whereas c-fos is commonly induced by both agents 4 .
The accessibility and assembly of transcription factor complexes at DNA regulatory regions, such as enhancers and promoters, are key regulatory elements of transcription and are tightly governed by the status of epigenetic modifications. Unique combinations of epigenetic marks and nucleosome positioning provide information for the activity of the underlying DNA sequence. Enhancers can be defined as intergenic and intragenic regions with elevated levels of monomethylation at Lys4 of the histone H3 subunit (H3K4me1), whereas promoter regions of active genes are enriched by trimethylation at the same residue 5 (H3K4me3). Even after establishment of the enhancer signature, the activity of enhancers can be suppressed (inactive), poised or induced, depending on cell type, developmental stage or extracellular signaling. Previous studies have identified more than 10,000 enhancers that control activity-dependent transcription in mouse cortical neurons and have shown that neuronal activity rapidly recruits RNA polymerase II (RNAPII) to a subset of ~2,500 neuronal enhancers and transcribes a novel class of long noncoding RNAs known as enhancer RNAs (eRNAs) 6 . Subsequent studies have established that eRNAs are expressed in a wide range of cell types and tissues in a manner that positively correlates with the expression of nearby mRNAs, which suggests that eRNA synthesis is an intrinsic regulatory mechanism of functionally active enhancers 7 . Transcription activity at enhancers appears to be a functionally important process, as the enhancer-specific H3K4me1 or H3K4me2 deposition at de novo enhancers occurs in an enhancer transcription-dependent manner 8 . eRNA transcripts have a r t I C l e S also been shown to function in target gene activation by mechanisms that vary depending on the cellular and/or genomic context 7 , indicating that enhancers have a more complex role in gene expression than previously thought.
Recent genome-scale studies of chromosomal organization have revealed that chromosomes are folded into topologically associating domains (TADs) that provide a three-dimensional (3D) structural barrier for enhancer sharing and allocation 9, 10 . Within each TAD, multiple dispersed enhancers are often physically associated with a common target gene by chromatin looping. About half of the active promoters in mammalian cells show interactions with multiple enhancers, with an average of 4.75 enhancers per active promoter 11, 12 . However, how and why multiple enhancers coordinately regulate a common target gene is not well understood. Several transgenic studies in Drosophila and mice have suggested a few different modes of enhancer integration. Discrete enhancers may simply have an additive effect on the expression of a common target gene, or they could be integrated, possibly with a functional hierarchy among the enhancer modules, to cause synergistic activation or allow fine-tuning (precision) and/or robustness of the transcriptional output in the face of dynamic environmental and genetic variability 13 . Most studies concerning the functionality of enhancer clusters have focused on developmentally regulated genes; to our knowledge, the coordinated action of enhancer modules in stimulus-dependent transcriptional induction has not yet been explored. A previous enhancer study in mouse cortical neurons showed that the c-fos gene is surrounded by five enhancers, dispersed throughout a ~50-kb region 6 . In primary neuronal cultures, c-fos transcription can be triggered by growth factors, cyclic AMP (cAMP) signaling and neurotransmitter-or KCl-induced membrane depolarization. Induction of c-fos expression has also been observed in the intact brain in response to a variety of physiological and pathological stimuli, including seizure, traumatic injury, somatosensory stimulation and long-term potentiation (LTP) 14 .
We reasoned that the several enhancers scattered around the c-fos gene might be dynamically coordinated to mediate robust c-fos induction in response to a wide range of stimuli. To test this idea, we determined the functionality of the c-fos enhancer cluster by investigating the autonomous activity and functional integration of individual enhancers during the induction of c-fos mRNA by three different stimuli (KCl-mediated membrane depolarization, BDNF and forskolin, which induce the cAMP pathway). Although all three stimuli efficiently induce c-fos transcription to similar degrees, each utilizes a distinct subset of enhancers and activity-regulated TFs to induce c-fos transcription. Characterizing individual c-fos enhancers by chromosome-conformation capture (3C) analysis and an enhancer reporter assay, we have corroborated the idea that eRNA is a reliable marker for identifying activated enhancers. We also evaluated the functionality of individual enhancers in their native context by targeted transcription silencing via CRISPR interference (CRISPRi). Using eRNA as a proxy for enhancer activity, we found that distinctive subsets of the c-fos enhancers are activated in the intact brain following chemically induced seizure or light stimulation. These results demonstrate that the combinatorial activation of the c-fos enhancers enables the c-fos gene to be broadly responsive to various signaling pathways.
RESULTS
The enhancer cluster surrounding the c-fos gene A previous genome-wide study revealed that the c-fos gene is surrounded by five activity-regulated enhancers 6 (Fig. 1a) . These enhancers show high levels of H3K4me1, whereas the c-fos promoter region is enriched with H3K4me3. Upon membrane depolarization of mouse cortical neurons, c-fos enhancers 1-5 (e1-e5) are inducibly bound by the general transcription coactivator CBP and several activityregulated TFs in various combinations (Supplementary Fig. 1 ). RNAPII is also inducibly recruited to each c-fos enhancer and synthesizes eRNAs, which have been shown to positively correlate with the activity of the enhancers from which they are expressed 6, 12, 15, 16 . These enhancers, which we identified in primary cultures of mouse cortical neurons, appear to be active in the intact brain throughout development, as all of them were tightly aligned with the chromatin immunoprecipitation (ChIP)-seq peaks of the active enhancer marker, acetylated H3K27 (H3K27ac) 17 (Supplementary Fig. 1 ). Although all five enhancers showed comparable levels of H3K4me1, the induction levels of RNAPII binding and eRNA expression at individual enhancers were different in that e1, e2 and e5 showed stronger transcription activity than e3 and e4 when neurons were depolarized by KCl. Notably, we observed that the active promoter mark H3K4me3 was also enriched at e2 and e5, which transcribe eRNAs at much higher levels than the other enhancers. Several recent studies have also reported that enhancers with high transcriptional activity are enriched with H3K4me3 and H3K4me1 marks [18] [19] [20] . These studies suggest that the H3K4me3/H3K4me1 ratio is positively correlated with transcription level, independently of transcript stability. We confirmed the induction of eRNAs by reverse transcriptionquantitative PCR (RT-qPCR) ( Fig. 1b ) and observed that, as with the kinetic relationship previously shown between eRNA and mRNA for the Arc and Gadd45b genes 21 , expression of all c-fos eRNAs peaked earlier than that of the c-fos mRNA. These results are consistent with a recent study that used genome-scale cap analysis of gene expression (CAGE) to show that enhancer transcription occurs most rapidly among the transcriptional changes during cellular differentiation or activation 22 .
Combinatorial activation of the c-fos enhancers
We reasoned that the previously observed broad inducibility of the c-fos gene might be enabled by synergistic and/or combinatorial actions of the surrounding enhancers. As the first step to test this idea, we treated neuronal cultures with three different stimuli-KCl (55 mM), BDNF and forskolin, which stimulates adenylate cyclase-to induce c-fos transcription, then measured eRNA induction levels 6, 12, 15, 16 ( Fig. 2a ). All three stimuli effectively increased c-fos mRNA levels ( Fig. 2a) . Consistent with the RNA-seq profile of cortical neurons, KCl-mediated membrane depolarization induced eRNA expression mainly from e1, e2 and e5. BDNF and forskolin activated different subsets of the c-fos enhancers: BDNF activated e1, e4 and e5, and forskolin activated e1 and e5 ( Fig. 2a) . In all cases, eRNA expression from enhancer e3 was not reliably detected, which is consistent with the previous observation that among the c-fos enhancers, e3 has the lowest H3K27ac level 17,23 ( Fig. 1 and Supplementary  Fig. 1 ). This result suggests that different stimuli promote c-fos transcription through the activation of distinct subsets of the surrounding enhancers.
We then used an enhancer reporter assay to examine whether individual enhancers can functionally regulate c-fos expression. We constructed a series of luciferase reporters in which each enhancer region was fused to a common minimal c-fos promoter region. We measured luciferase activity in neuronal cultures that had been transfected with each reporter and treated with KCl, BDNF and forskolin (Fig. 2b) . We found that the same subset of enhancers that was active in eRNA production upon each stimulus also promoted npg a r t I C l e S luciferase reporter expression. As enhancer loci and activities vary widely in different cell and tissue types 24 , we wondered whether the five c-fos enhancer regions we identified in our in vitro culture of mouse cortical neurons are preserved in other tissues. Examining publicly available H3K27ac enrichment profiles in forebrain, heart and liver 17 , we found that e2, e4 and e5 are active in all three tissues ( Supplementary Fig. 1 ). The e1 enhancer was active in the heart and brain but not in liver, suggesting that its activity is tissue specific. The H3K27ac level near the e3 enhancer was lower than near the other enhancers in all three tissues. We also measured the levels of eRNA induction from each enhancer in NIH 3T3 cells after serum stimulation and found that e5 and e4 were the only two enhancers that transcribe eRNAs upon serum stimulation ( Supplementary  Fig. 2a ). The luciferase reporter assay further showed that e5 was the most responsive to serum stimulation in NIH 3T3 cells ( Supplementary Fig. 2b ). We then compared the activities of luciferase reporters driven by single enhancers to those driven by combinations of multiple enhancers to examine whether stimulusspecific combinations of enhancers contributed to synergistic gene activation ( Fig. 2c) . In this assay, we investigated the activity of e1 alone; combinations of the KCl-, BDNF-and forskolin-activated enhancers (e1-e2-e5, e1-e4-e5 and e1-e5, respectively) and all four major enhancers (e1-e2-e4-e5). As compared to e1 alone, the combination of KCl-activated enhancers (e1-e2-e5) synergistically increased luciferase reporter expression to a level comparable to that driven by all four enhancers upon KCl stimulation. Likewise, the BDNFspecific enhancer combination (e1-e4-e5) synergistically increased the reporter expression to the level of four-enhancer combination when neurons were stimulated by BDNF. Forskolin stimulation of these reporter constructs yielded a similar result. The combinations e1-e2-e5 and e1-e5 showed similar levels of reporter activity when stimulated by BDNF or forskolin, confirming that neither stimulus induces e2 activity. Likewise, addition of e4 in KCl stimulation (e1-e4-e5) did not increase reporter activity more than the e1-e5 combination. These findings demonstrate that distinct combinations of enhancers are used to induce c-fos expression depending on the types of stimuli or cells.
Interactions between enhancers and the c-fos promoter
Chromosomal looping allows enhancers to be juxtaposed to their specific target promoters to regulate gene expression. We determined the chromosomal interactions between each of the c-fos enhancers and the promoter before and after stimulus by 3C analysis to see whether the members of the stimulus-specific enhancer subset would selectively npg a r t I C l e S interact with the c-fos promoter and whether the enhancer-promoter interactions occur in a stimulus-dependent manner. In this 3C assay, we were able to reliably analyze only the e1, e2 and e5 enhancer regions. Enhancers e3 and e4 are located less than ~4 kb from the c-fos promoter, which prevented us from measuring their specific interactions with the promoter (both the rate of random collision and cross-linking efficiency increase significantly as the genomic distance between two restriction enzyme-digested genomic fragments decreases) 25 . Despite this limitation, the 3C result was consistent with the stimulusspecific eRNA induction profile and the luciferase reporter assay. Both e1 and e5 regions rapidly interacted with the c-fos promoter upon stimulation by all three stimuli, whereas only KCl stimulation caused a detectable increase in the interaction between e2 and the promoter ( Fig. 3) . Previous work has shown that the chromosomal interaction between the enhancer and the promoter for the Arc gene occurs inducibly upon KCl stimulation 21 ; therefore, it seems that the induction of IEGs in neurons involves stimulus-induced chromosomal looping between the enhancer and promoter.
Transcription factors in KCl-mediated c-fos induction
Having confirmed the activities of the c-fos enhancers in neurons, we next asked whether and how activity-regulated TFs are functionally required for c-fos expression in response to different stimuli. ChIPseq analysis has revealed that the c-fos promoter and enhancers were bound by different combinations of several activity-regulated TFs 6 ( Supplementary Fig. 1 ). Serum response factor (SRF) occurred mainly at the promoter and at e5, regardless of membrane depolarization. We found that CREB binds to the promoter as well as e1 and e2, and binding frequency was slightly increased by KCl. However, both CBP and NPAS4 bound in a depolarization-dependent manner to all enhancers and weakly to the c-fos promoter. For comparison, we scanned each enhancer for the presence of canonical binding motifs of the activity-regulated TFs CREB, MEF2 and SRF using RSAT software 26 and found that cognate binding motifs were present for all of the experimentally determined TF binding sites, though not all were bound by their corresponding TFs ( Supplementary Fig. 3a,b) .
Notably, we found that e1, e2 and e5 have canonical binding motifs for all three TFs, whereas the e3 and e4 contain only the MEF2 binding motif. To examine the functional requirement of each TF for different stimuli, we transduced neurons with lentiviruses expressing small hairpin RNAs (shRNAs) targeting several activity-regulated TFs (CREB, SRF, MEF2A, MEF2D, MEF2C and NPAS4) and monitored how shRNA-mediated knockdown of each TF affected the stimulus-dependent induction of c-fos mRNA and eRNAs. Knockdown of CREB, MEF2A and NPAS4 significantly impaired c-fos induction by KCl-mediated membrane depolarization ( Fig. 4a and Supplementary  Fig. 4 ). Although knockdown of MEF2 family members MEF2D and MEF2C showed a slight decrease in c-fos expression, it was not significant and had a weaker impact than MEF2A knockdown. The decrease in c-fos expression was paralleled with little effect on eRNA transcription ( Supplementary Fig. 5 ). This result was surprising, especially given that MEF2C was the most abundantly expressed isoform in mouse cortical neuron culture (Supplementary Fig. 6 ).
It is unlikely that the result was due to the differences in knockdown efficiency, as the decreases in RNA levels of the TFs were comparable ( Supplementary Figs. 5 and 6) . Knockdown of SRF did not affect c-fos mRNA level. Consistently, knockdown of these TFs did not affect eRNA expression induced by KCl stimulation ( Supplementary  Fig. 5 ). This result is inconsistent with a previous study showing that SRF contributes to KCl-mediated induction of c-fos transcription in PC12 cells 27 . This discrepancy may result from some physiological difference between PC12 cells and primary neurons. Moreover, the analysis in PC12 cells was based on a transient expression assay with the plasmid containing the c-fos promoter region only, thus not accurately reflecting the endogenous genomic context where the surrounding enhancers are also active. It is also plausible that SRF activity can be efficiently compensated for by other activity-regulated TFs in neurons. Cellular heterogeneity could have been a confounding factor in our analysis, as c-fos is induced in many different cell npg a r t I C l e S types, including glial cells and neurons. To investigate this issue, we used immunostaining for GFAP and Tuj-1 (markers of glia and neurons, respectively) to assess the numbers of neurons and glia cells present in a typical embryonic culture of mouse cortical neurons at 6 d in vitro (DIV 6). We found that glial cells were strongly outnumbered by neurons (1.2% versus 93% of DAPI-positive cells, respectively) ( Supplementary Fig. 7a,b ), suggesting that any contribution from glial cells was likely to be insignificant. We also prepared glial cell cultures and measured induction levels of c-fos mRNA as well as eRNAs in response to KCl, BDNF and forskolin ( Supplementary Fig. 7) .
Forskolin was the strongest inducer of the c-fos gene, followed by BDNF then KCl. Notably, eRNA activation patterns were different from those in neuronal cultures. The c-fos enhancers showed a low response to KCl. Both BDNF and forskolin activated all c-fos enhancers by more than twofold. Therefore, the observed enhancer activation patterns in our in vitro culture were probably a result of neuronspecific responses to the stimulus. We also found that the decrease in c-fos mRNA level was caused mainly by reduced activation of e2 and e5, as the levels of eRNAs at those two enhancers were decreased by the knockdown of CREB, MEF2A and NPAS4 (Fig. 4b) . The e1 enhancer was also active upon KCl stimulation, as judged by eRNA expression, but knockdown of each TF had little effect on e1 expression, suggesting that another, unknown TF might have a redundant or more important function at the e1 enhancer. However, as there was a slight decrease in e1 eRNA upon TF knockdown (Fig. 4b) , it is also possible that the low expression of e1 eRNA affects the accuracy of measuring the dynamic change in e1 eRNA expression. A previous study of Npas4-knockout neurons showed that NPAS4 is functionally required for expression of several IEGs, including c-fos, despite the fact that NPAS4 expression is regulated by neuronal activity 28 . NPAS4 was unique among the activity-regulated TFs we investigated in that it bound to all c-fos enhancers but not to the promoter 6 (Supplementary Fig. 1 ). This result suggests that NPAS4 contributes to the KCl-mediated induction of the c-fos gene exclusively by regulating the activity of enhancers. Taken together, these results reveal that e2 and e5 enhancers are crucial for KCl-induced c-fos expression in which a subset of activity-regulated TFs, CREB, MEF2A and NPAS4 have an important function.
Transcription factors in BDNF-mediated c-fos induction
We performed a similar experiment with BDNF stimulation to test whether BDNF signaling requires a different set of TFs for c-fos induction. Unlike KCl stimulation, knockdown of MEF2A, but not CREB or SRF, significantly reduced the level of c-fos induction when neurons were stimulated by BDNF (Fig. 4c) . SRF is required for c-fos induction by growth factors in PC12 cells 29 ; however, in neurons we could not detect significant impairment in BDNF-dependent induction of endogenous c-fos by SRF knockdown. As neither of the stimuli showed a requirement of SRF for c-fos induction, we tested the IEGs Arc and Egr1 for SRF-dependent expression and found that SRF knockdown significantly (P = 0.0481, unpaired t-test) impaired KCl-dependent induction of Arc and Egr1 (Supplementary Fig. 8 ). This result further demonstrates that the small or absent effect of SRF knockdown on c-fos induction is unlikely to be due to insufficient knockdown of SRF. We did not analyze NPAS4 for BDNF stimulation, as the basal level of NPAS4 protein is very low in neurons and its induction strictly requires membrane depolarization-mediated calcium signaling 30 . We next examined the effect of TF knockdown on BDNF-dependent eRNA expression. In wild-type (WT) or neurons infected with a scrambled control shRNA, BDNF stimulation triggered rapid induction of eRNAs from e1, e4 and e5, whereas KCl-mediated membrane depolarization induced eRNA transcription from e1, e2 and e5 ( Fig. 2a) , indicating that e2 and e4 are uniquely responsive to KCl and BDNF, respectively. The decrease in BDNFinduced c-fos mRNA level by MEF2A knockdown was paralleled by a decrease in eRNA levels at e4 and e5 (Fig. 4d) . Consistently, motif analysis showed that both e4 and e5 enhancers have multiple MEF2 binding sites (Supplementary Fig. 3a,b) . Similarly to our observations with KCl stimulation, BDNF-dependent expression of e1 eRNAs was not significantly affected by the MEF2A knockdown. These results demonstrate that BDNF-induced expression of c-fos is mediated by MEF2A, which acts mainly on enhancers e4 and e5. Because MEF2A is important for both KCl-and We observed MEF2A binding at four enhancers (e1, e2, e4 and e5) as well as the promoter, some of which also showed further increase in MEF2 binding in a stimulus-specific manner (Supplementary Fig. 9 ).
CRISPRi analysis of individual c-fos enhancers
The results of the eRNA induction profile, enhancer reporter assay and TF knockdown suggest that the e2 and e4 enhancers are selectively activated by KCl and BDNF, respectively. To further verify this observation, we used the CRISPRi system, in which a catalytically inactivated mutant form of Cas9 (dCaps9) is fused to the Krüppel-associated box (KRAB) domain of Kox1 (ref. 31 ). The KRAB domain can recruit KAP1, which acts as a scaffold for various heterochromatininducing factors, such as heterochromatin protein 1 (HP1) and the histone methyltransferase SETDB1. The dCas9-KRAB fusion protein guided by single-guide RNA (sgRNA) has been shown to efficiently silence expression of target genes 31, 32 . We used CRISPRi to selectively silence the activity of individual c-fos enhancers and examined how that affected c-fos induction in response to KCl or BDNF. We first directed dCas9-KRAB to the c-fos transcription start site (TSS) and observed a decrease in KCl-induced transcription of c-fos but not other IEGs, demonstrating the specificity of the system (Fig. 5a) . dCas9-KRAB caused a significant decrease in KCl-or BDNF-induced eRNA transcription (Fig. 5b) .
CRISPRi-mediated inhibition appeared to be specific to the targeted enhancer, as blocking e2 reduced the activity of e2 but not the other c-fos enhancers (Supplementary Fig. 10 ). On the basis of the CRISPRi analysis with e5, CRISPRi may also impair the physical interaction between the targeted enhancer and the promoter ( Supplementary  Fig. 11 ). We then examined whether CRISPRi-mediated inhibition a r t I C l e S of individual enhancers affected the c-fos expression induced by KCl or BDNF (Fig. 5c ). We measured levels of pre-mRNA in parallel with mRNA to evaluate the impact of CRISPRi more specifically on de novo transcription activity at the c-fos gene. CRISPRi at e2 and e5 caused a significant decrease in the induction levels of both RNA populations of the c-fos gene whereas suppression of e4 and e5 enhancer activities impaired BDNF-induced c-fos expression. The induction of other IEGs (Arc, Gadd45b and Egr1) was not affected by CRISPRi (Supplementary Fig. 12 ). Together with the eRNA induction profiles and luciferase reporter data, our CRISPRi analysis demonstrates that the e2 and e4 enhancers functionally contribute to the c-fos gene induction by specifically responding to KCl and BDNF stimulation, respectively. Blocking e1 activity in the native context by CRISPRi did not have any impact on c-fos induction by either stimulus, despite its inducible interaction with the c-fos promoter and eRNA transcription. We also showed by luciferase assay that e1 alone could enhance reporter expression in response to all three stimuli. On the basis of these results, we propose that e1 acts as a 'shadow enhancer' for c-fos expression, ensuring precise and robust transcription of target genes during extreme or adverse conditions that may occur throughout development and/or by dynamic environmental changes yet is otherwise dispensable owing to functionally redundant primary enhancers 33 .
Combinatorial activation of c-fos enhancers in the brain
We next asked whether combinatorial activation of c-fos enhancers also occurs in the brain. First we examined whether different brain regions activate distinctive sets of the c-fos enhancers to mediate c-fos induction upon chemically induced seizure. Young adult mice were injected intraperitoneally with kainic acid (KA), which activates glutamate receptors to induce seizure. One hour after KA injection, we detected strong c-fos mRNA induction in the cerebral cortex and hippocampus and weak induction in the cerebellum 34 (Fig. 6a) . We then measured individual eRNA levels in those brain regions. A single injection of KA led to induction of c-fos eRNAs from e4 and e5 in the cerebral cortex, whereas eRNAs from four c-fos enhancers (all but e3) were induced in the hippocampus. We did not detect induction of eRNA in the cerebellum, possibly because the KA-induced c-fos mRNA induction level was lower than in other brain regions. We also investigated whether sensory stimulation can trigger eRNA transcription from the c-fos enhancers in the intact brain. We took dark-reared mice and stimulated their visual cortex by light for 1 h.
RT-qPCR analysis of the RNAs isolated from the visual cortex after visual stimulation detected eRNAs only from the e5 enhancer region (Fig. 6b) . These results support our in vitro findings that different combinations of enhancers are used to ensure c-fos induction in response to various stimuli and illustrate region-specific combinatorial activation of the c-fos enhancers. We wondered whether our finding, from the in vitro study, that e2 and e4 are uniquely responsive to KCl and BDNF, respectively, could be observed in the intact brain. However, unlike in our in vitro culture system, any sensory or chemical stimulation to the intact brain would involve multiple, intricately intersecting signaling pathways. Despite this confounding issue, we attempted to investigate BDNF-induced activation of c-fos enhancers in the hippocampus. We directly injected recombinant BDNF into the hippocampus and analyzed both c-fos mRNA and eRNAs 1 h later (Fig. 7a) . A direct BDNF injection induced c-fos mRNA ~10-fold in the hippocampus, compared to PBS injection (Fig. 7b) . In parallel, e4 and e5 activity were increased mainly by BDNF. Notably, this pattern of enhancer activation (with the exception of the e1 enhancer) is similar to the one observed in the in vitro neuronal culture stimulated by BDNF despite the considerable differences between the two experimental systems, such as cell type and developmental stage. We next investigated whether any BDNF-activated enhancers would be functionally important for BDNF-induced c-fos expression. We used Bdnf conditional knockout (KO) mice, in which Bdnf has been selectively deleted in neurons during late embryogenesis 35 . We then induced seizure by KA in both Bdnf KO and littermate control mice and compared the expression levels of the c-fos mRNA and eRNAs between the two groups (Fig. 7c) . Whereas KA-induced seizure increased c-fos expression in the hippocampus of control mice, the induction level of the c-fos gene was diminished in conditional Bdnf KO mice. This result implies that the downstream signaling pathways triggered by KA and BDNF significantly overlap or intersect. Notably, KA-induced activation of e4 was severely impaired by Bdnf deletion, whereas e5 enhancer activity was unaltered. These results strongly suggest that e4 enhancer is selectively responsive to BDNF-induced signaling pathways both in vitro and in vivo.
DISCUSSION
In this study, we demonstrate that multiple enhancers located near the c-fos gene can be activated in distinct combinations in response to various stimuli or in different brain regions. We propose that such npg a r t I C l e S combinatorial activation of enhancers present within a cluster could be a mechanism to allow the c-fos gene to be robustly responsive to a wide range of stimuli. As a consequence of such a mechanism, each stimulus exhibits a differential functional requirement of TFs, each of which also shows a distinct binding specificity in the c-fos gene area.
The c-fos gene is a prototypical IEG whose rapid and transient expression was originally observed in NIH 3T3 cells, in which the c-fos mRNA level rises within several minutes in response to the platelet-derived growth factor (PDGF) and subsides in ~30 min 36 . In primary neuronal cultures, rapid c-fos transcription can be triggered by growth factors, a cAMP analog or membrane depolarization induced by neurotransmitters or KCl 14 . Induction of c-fos expression has also been observed in the intact brain in response to a variety of physiological and pathological stimuli, including seizure, traumatic injury, somatosensory stimulation and LTP 14 . c-fos expression correlates well with neuronal activity and in some cases has been thought to represent the synaptic plasticity response of neurons 37 . c-fos is a popular marker for mapping functional neural circuits involved in sensory information processing, owing to its rapid and transient expression kinetics with very low background level, as well as its responsiveness to such a broad range of stimuli. Suppression of c-fos expression by antisense oligonucleotide-mediated knockdown or genetic deletion of the c-fos gene in mice caused defects in learning behaviors such as fear and spatial learning and conditioned place preference [38] [39] [40] . At the molecular level, c-FOS has been shown to regulate a wide range of activity-regulated genes that control synaptic function through its binding almost exclusively to neuronal enhancers 23 .
The rationale of this study was twofold. First, we wanted to determine the molecular mechanism that enables robust and reliable expression of the c-fos gene in response to various stimuli, which would help to understand the gene regulatory logic in multicellular organisms that has evolved to control gene expression with high precision and efficiency in the face of dynamic environmental changes and developmental cues. Second, we wanted to develop in vivo IEG reporters that are not only more potent in driving the expression of a fluorescent reporter protein but also selectively responsive to a particular signal. c-fos-based transgenic reporter mouse lines have been used to detect neuronal populations that are activated by behavioral or pharmacological stimuli 41, 42 . However, these mice utilize only the c-fos promoter region to induce the reporter fluorescent protein and do not include any of the c-fos enhancers we have characterized. On the basis of our findings, the promoter-only reporters might not faithfully recapitulate the expression characteristics of the endogenous c-fos gene in vivo triggered by sensory or pharmacological stimuli. We have shown that combination of an enhancer with the c-fos minimal promoter can significantly increase the induction level of the luciferase reporter in a stimulus-specific manner. Therefore, an array of reporters in which expression of a fluorescent protein is controlled by the c-fos promoter combined with one or more of the surrounding enhancers could serve as a versatile tool kit for the analysis of sensory stimulation-specific activation of particular neural circuits or populations in vivo and in acute brain slices.
Why are some genes regulated by multiple enhancers, whereas others are not? Although this question would require much work to be fully understood, several genetic studies of developmentally crucial genes suggest that enhancers with extensively overlapping activities help to ensure the robustness and precision of their expression in natural populations in the face of environmental and genetic variations 33 . Evidence also suggests some other mechanisms of enhancer coordination 13 . Multiple enhancers may simply decrease the failure rate in target gene expression by increasing the occurrence of productive interaction with their target gene. In some cases, different enhancers have nonredundant functions, acting sequentially during the developmental process of gene activation, as in the regulation of the HoxD gene cluster during limb development 43 . Our study demonstrates another mode of enhancer coordination, in which distinct subsets of enhancers dynamically respond to different types of stimuli to ensure the robust induction capacity of the c-fos gene. An interesting question related to our study is how many and what types of genes are subject to the coordination of multiple enhancers similarly to the c-fos gene. A 3D chromatin interactome study in primary human fibroblast cells (IMR90) has shown that 46% of active genes do not interact with distal enhancers, and highly transcribed housekeeping genes are enriched in this group 11 . The rest of the active genes make extensive interactions with enhancers and are enriched for cell type-specific functions, including signal transduction. In addition, recently defined super-enhancers, a set of clustered enhancers that show an exceptionally high level of transcriptional activators or active enhancer chromatin marks such as H3K27ac, are also enriched near genes that function in cell identity or in cell type-specific pathways 44, 45 . To the best of our knowledge, such a genome-wide analysis of chromosomal interactome has not been performed in the brain. Nonetheless, we provide here two additional inducible genes that appear to be regulated by multiple enhancers in a stimulus-dependent manner. The Peli1 gene is rapidly induced by either KCl or BDNF and multiple enhancers are located upstream of the gene (Supplementary Fig. 13 ). The eRNA expression analysis of four putative Peli1 enhancers revealed KCl-and BDNF-specific activation patterns of the enhancers. Igf1 is not an IEG yet still appears to be regulated by dynamics between multiple enhancers ( Supplementary  Fig. 14) . Selective activation of e2 and e3 enhancers was observed by 6 h KCl stimulation. Notably, those two enhancers appear to be activated more rapidly by BDNF stimulation, with e1 enhancer activated at 6 h. Although these are preliminary results, it is possible that combinatorial action of multiple enhancers can be achieved spatially and/or temporally.
The c-fos enhancers can probably be classified as 'super-enhancers' . A recent study showed that super-enhancers are the major platform to which multiple signaling pathways converge to regulate genes that have prominent roles in development and tumorigenesis 46 . The c-fos enhancers are clustered within a ~50-kb region flanking the c-fos gene and are highly enriched with H3K27ac in the forebrain throughout development 17 (Supplementary Fig. 1) . They also show strong binding levels of key activity-regulated TFs in various combinations 6 (Supplementary Fig. 1) . Although most of the activity-regulated TFs are broadly expressed throughout the brain, their downstream target genes and physiological functions in synapse development are distinct 14 . Our study illustrates how the transcription output of each mammalian gene is controlled by the combinatorial interactions of multiple TFs that occur at the enhancers and the promoter. We also show that the functional requirement of individual TFs for the c-fos gene varies depending on the type of stimulation and, possibly, the brain regions, and that this variation is in part mediated by the combinatorial use of multiple enhancers (Supplementary Fig. 15 ).
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper. npg a r t I C l e S luciferase reporter assay. Cultured primary cortical neurons were transfected using the calcium phosphate precipitation method at DIV3 and harvested at DIV6. The NIH3T3 cells were transfected at 70% confluency using fugene HD (Promega). NIH3T3 cells are from American Type Culture Collection (ATCC Manassas, VA, USA), and were authenticated using the DNA Sanger Sequencing Mlutiplex PCR Assay. The cells were not tested for mycoplasma contamination. The entire sequences of c-fos eRNA and promoter regions were amplified by PCR using a BAC clone (CHORI, RP24-233K8) and reporter constructs were generated with the firefly luciferase reporter plasmid pGL4.11[luc2P] (Promega). The pGL4.11-c-fosPromoter-luc2P plasmid, which contains 361 nucleotides from the start site and includes the first exon and intron sequence (212 nucleotides), was generated as the c-fos promoter region. Each of the full-length c-fos eRNAs were subcloned into the KpnI/NheI or KpnI/SacI sites of the pGL4.11c-fosPromoter-luc2P plasmid. Detailed c-fos eRNA genomic locations were as follows: pGL4.11-c-fose1Promoter-luc2P (+39.554 to +35.802 kb from start site); pGL4.11-c-fose2Promoter-luc2P (+20.034 to +16.454 kb from start site); pGL4.11-c-fose3Promoter-luc2P (+6.811 to +5.12 kb from start site); pGL4.11c-fose4Promoter-luc2P (+3.432 to +1.167 kb from start site); pGL4.11-c-fose5-Promoter-luc2P (-9.955 to −5.591 kb from start site). Genomic locations for combinational c-fos eRNA luciferase assay were as follows: pGL4.11-c-fose1 + e2 + e4 + e5Promoter-luc2P (e1: +37.887 to +38.387 kb, e2: +18.482 to +17.990 kb, e4: +2.218 to 1.718 kb, e5: −12.160 to −12.648 kb from start site); pGL4.11-c-fose1 + e2 + e5Promoter-luc2P (e1: +37.887 to +38.387 kb, e2: +18.482 to +17.990 kb, e5: −12.160 to −12.648 kb from start site); pGL4.11-c-fose1 + e4 + e5Promoter-luc2P (e1: +37.887 to +38.387 kb, e4: +2.218 to 1.718 kb, e5: −12.160 to −12.648 kb from start site); pGL4.11-c-fose1 + e5Promoter-luc2P (e1: +38.387 to +37.887 kb, e5: −12.160 to −12.648 kb from start site).
kA injection and visual stimulation. Adult C57BL/6 mice (2-4 months), wildtype and Bdnf knockout mice (4-6 months) 35 were injected intraperitoneally with kainic acid (KA, Tocris) dissolved in 0.9% saline at 20 mg per kg body weight (mg/kg), and control mice were injected with the same volume of 0.9% saline. Animals were sacrificed at 1 h after the injection. In the visual stimulation experiment, mice were placed in dark controlled environmental chambers for light deprivation. After 6 d, mice were taken out from the controlled environmental chambers and exposed to a lighted environment for 1 h, then the visual cortex was isolated from the brain. Using TRIzol reagent, total RNA was isolated from the cortex, hippocampus, cerebellum, and visual cortex, and then cDNA was synthesized. npg transcription repression by cRISPR-dcas9-kRAB (cRISPRi). The c-fos promoter and enhancer target specific single guide RNAs (sgRNAs) were designed using the E-CRISPR design tool 51 . Both of the lentiviral backbone plasmids, pHR-SFFV-dCas9-BFP-KRAB 31 and lentiGuide-Puro 52 were obtained from Addgene. The annealed DNA was cloned into the BsmBI site of the lentiGuide-Puro vector. The pHR-SFFV-dCas9-BFP-KRAB and lentiGuide-Puro-sgRNA, with the helper plasmids ∆8.9 and VsVg constructs, were transfected into HEK293T cells using Fugene-HD for 48-72 h. The targeted promoter, e1, e2, e4, and e5 sequences were as follows, promoter, 5′-AGAAGACTGGATAGAGCCGG-3′; e1, 5′-TGGGAAGCAGGACAGACTGG-3′; e2, 5′-ATTAGAAAGTGCT GAGGCGG-3; e4, 5′-GGATGGATCTTTAGGGGCGC-3; e5, 5′-ACCGCCCT GGCGCTCAGACC-3. Collected lentiviral supernatant was added to DIV3 neurons, and cells were harvested at DIV6.
BdnF stereotaxic injection. Two-month-old male C57BL/6 mice were anesthetized with tribromoethanol (200 mg/kg, Sigma). 25 ng of BDNF was injected with a glass pipette in to the dorsal hippocampal CA1 region with the following coordinates, anteroposterior (AP) +1.90 mm, medial lateral (ML) ±1.25 mm, dorsal ventral (DV) −1.20 mm. Animals were sacrificed 1 h after the stereotaxic injection, and then the hippocampus was isolated from the brain.
Immunocytochemistry. DIV 6 primary cortical neurons and glial cells were fixed and permeabilized with 4% paraformaldehyde in PBS and 0.25% Tritron X-100 in PBS, respectively, and then incubated with primary antibody against Tuj-1 (Covance, 1:500) and GFAP (Sigma, 1:500). For secondary antibodies, Alexa Fluor 488-or Alexa Fluor 555-conjugated anti-IgG (Invitrogen, 1:600) antibodies were used. Cells were mounted in Vectashield mounting medium with DAPI (Vector laboratories) for fluorescence analysis, and imaged with a fluorescence microscope (Olympus LX51). chromatin immunoprecipitation (chIP). ChIP assay was performed as previously published 21 . Briefly, at DIV6 cultured cortical neurons were incubated with KCl (55 mM) for 30 min and BDNF (10 ng/ml) or forskolin (10 µM) at DIV6 for 1 h. Subsequently, cell lysates were incubated overnight with anti-Mef2a 53 then incubated with Protein A/G agarose beads (Santa Cruz). DNA was then purified and analyzed with RT-qPCR. Figs. 6 and 16 ) was performed as previously published 21 . Antibodies used were anti-Mef2A (1:1,000) 53 , anti-Mef2C (Proteintech, 1:500), anti-Mef2D 53 , or anti-β-actin (Sigma-Aldrich, 1:5,000). Images were acquired by Odyssey (LI-COR).
western blot analysis. Western blot analysis (Supplementary
Statistical analyses. Statistical analysis was performed using unpaired Student's t-test and unpaired t-test with Welch correction. No statistical methods were used to pre-determine sample size, but our sample sizes are similar to those used commonly in the field. Unpaired Student's t-test and unpaired t-test with Welch correction were performed for comparison between two groups of samples. Data distribution was assumed to be normal, but this was not formally tested. Randomization and blinding were not used. We considered P < 0.05 to be statistically significant. Detailed statistical information for each figure is given below. Figure 2 . For c-fos mRNA, KCl P = 0.0418, t(2) = 4.736, n = 3; BDNF P = 0.0333, t(2) = 5.339, n = 3; forskolin P = 0.0448, t(2) = 4.566, n = 3, unpaired two-tailed t-test with Welch correction; for c-fos eRNA with KCl, e1 P = 0.0418, t(4) = 6.654, F = 10.187 (P value from comparing the s.d. for both groups (SDP) = 0.0894), n = 3; e2 P = 0.008, t(4) = 11.103, F = 3.149 (SDP) = 0.3267), n = 3; e5 P = 0.0264, t(4) = 3.436, F = 26.341 (SDP = 0.0566), n = 3 (unpaired two-tailed t-test); for c-fos eRNA with BDNF, e1 P = 0.0329, t(4) = 3.200, F = 16.876 (SDP = 0.0599), n = 3; e4 P = 0.0271, t(4) = 3.408, F = 17.578 (SDP = 0.0538), n = 3, unpaired t-test; e5 P = 0.0214, t(2) = 6.723, n = 3, unpaired two-tailed t-test with Welch correction; forskolin, e1 P = 0.0498, t(4) = 2.718, F = 6.333 (SDP = 0.1364), n = 3; e5 P = 0.0485, t(4) = 2.805, F = 4.048 (SDP = 0.1981), n = 3 biological replicates, unpaired two-tailed t-test ( Fig. 2a) . KCl, e1 P = 0.0242, t(3) = 6.306, n = 4; e2 P = 0.0103, t(3) = 5.784, n = 4; e5: P = 0.0191, t(2) = 7.140, n = 3; BDNF, e1 P = 0.0350, t(2) = 5.207, n = 3; e4 P = 0.0056, t(2) = 13.349, n = 3; e5 P = 0.0391 t(2) = 4.907, n = 3; forskolin, e1 P = 0.0087, t(2) = 10.633, n = 3; e5 P = 0.0438, t(2) = 4.618, n = 3 (biological replicates, unpaired two-tailed t-test with Welch correction) (Fig. 2b) ; KCl, e1-e2-e4-e5 P = 0.0001, t(5) = 12.256, n = 6; e1-e2-e5 P = 0.0246, t(2) = 6.259, n = 2; e1-e4-e5 P = 0.0240, t(2) = 6.576, n = 2; e1-e5 P = 0.0128, t(2) = 8.764, n = 2 (biological replicates, unpaired two-tailed t-test with Welch correction); BDNF, e1-e2-e4-e5 P = 0.0007, t(7) = 5.818, n = 6 (unpaired two-tailed t-test with Welch correction); e1-e2-e5 P = 0.0034, t(3) = 8.537, F = 1.411 (SDP = 0.3569), n = 3; e1-e4-e5 P = 0.0004, t(3) = 18.125, F = 6.346 (SDP = 0.1280), n = 3; e1-e5 P = 0.00303, t(3) = 2.822, F = 63.970 (SDP = 0.0946), n = 3 (biological replicates, unpaired two-tailed t-test); forskolin, e1-e2-e4-e5 P = 0.0001, t(5) = 12.601, n = 6, unpaired two-tailed t-test with Welch correction; e1-e2-e5 P = 0.0189, t(2) = 7.164, F = 126.28 (SDP = 0.0565), n = 3 (biological replicates, unpaired two-tailed t-test) (Fig. 2c) . SDP > 0.05 indicates that s.d. values are not significantly different and can be used for an unpaired t-test. Figure 3 . For KCl stimulation, [e1]: P = 0.0452, t(2) = 4.545, n = 3, unpaired t-test with Welch correction; [e2]: P = 0.0109, t(4) = 4.492, F = 5.459 (SDP = 0.1548), n = 5, unpaired t-test (Fig. 3b) ; [e5]: P = 0.0492, t(2) = 3.554, n = 3, unpaired t-test with Welch correction (Fig. 3f) ; [e1]: P = 0.0482, t(2) = 4.389, n = 3, unpaired t-test with Welch correction; [e5]: P = 0.0001, t(4) = 14.393, F = 2.872 (SDP = 0.2583), n = 3, unpaired t-test (Fig. 3c,g) ; For BDNF stimulation, [e1]: P = 0.0482, t(2) = 4.389, n = 3, unpaired t-test with Welch correction (Fig. 3c) , [e5]: P = 0.0001, t(4) = 14.393, F = 2.872 [SDP = 0.2583], n = 3, unpaired t-test (Fig. 3g) ; For Forskolin stimulation, [e1]: P = 0.0016, t(2) = 7.132, F = 49.091 (SDP = 0.0903), n = 3 (Fig. 3d) ; [e5]: P = 0.0489, t(2) = 3.481, F = 8.843 (SDP = 0.2065), n = 3 biological replicates, unpaired t-test (Fig. 3h) . P values are from a two-tailed t-test. SDP is the P value from comparing the s.d. for both groups. SDP > 0.05 means the two SDs are not significantly different and can be used for an unpaired t-test. Figure 4 . c-fos mRNA, KCl stimulation: shCREB P = 0.0222, t(2) = 6.600, F = 27.833 (SDP = 0.1192), n = 3; shMEF2A, P = 0.0417, t(2) = 4.741, F = 11.189 (SDP = 0.1849), n = 3; shNPAS4, P = 0.0455, t(2) = 4.524, F = 28.538 (SDP = 0.1178), n = 3; c-fos eRNA, KCl stimulation: e2, P = 0.0382, t(4) = 3.046, F = 1.078 (SDP = 0.4813), n = 3, e5, P = 0.0478, t(4) = 2.820, F = 3.517 (SDP = 0.2214), n = 3 for shCREB; e2, P = 0.0339, t(4) = 3.169, F = 2.995 (SDP = 0.2503), n = 3, e5, P = 0.0101, t(4) = 5.812, F = 2.441 (SDP = 0.2586), n = 3 for shMEF2A; e2, P = 0.0164, t(2) = 7.714, F = 9.324 (SDP = 0.2015), n = 2 for shNPAS4; c-fos mRNA, BDNF stimulation: shMEF2A, P = 0.0001, t(4) = 8.656, F = 2.157 (SDP = 0.3168), n = 3; c-fos eRNA, BDNF stimulation: e4, P = 0.0439, t(3) = 2.906, F = 8.631 (SDP = 0.1038), n = 3, e5, P = 0.0485, t(4) = 2.807, F = 5.381 (SDP = 0.1567), n = 3 for shMEF2A; unpaired two-tailed t-test. SDP is the P value from comparing the s.d. for both groups. SDP > 0.05 means the two s.d. values are not significantly different and can be used for an unpaired t-test. Figure 5 . P = 0.0189, t(2) = 12.637, F = 4.830 (SDP = 0.2718), n = 3 biological replicates (Fig. 5a) . c-fos e1 eRNA, P = 0.0151, t(2) = 8.037, F = 4.147 (SDP = 0.2906), n = 2; c-fos e2 eRNA, P = 0.0393, t(4) = 3.015, F = 3.461 (SDP = 0.2242), n = 3; c-fos e4 eRNA, P = 0.0206, t(2) = 6.864, F = 25.000 (SDP = 0.1257), n = 2; c-fos e5 eRNA, P = 0.0104, t(2) = 9.711, F = 32.398 (SDP = 0.1107), n = 2 biological replicates ( Fig. 5b) . KCl stimulation: e2 c-fos pre-mRNA, P = 0.0433, t(4) = 2.918, F = 1.388 (SDP = 0.4187), n = 3; c-fos mRNA, P = 0.0102, t(8) = 3.340, F = 1.114 (SDP = 0.459), n = 5; e5 c-fos pre-mRNA P = 0.0077, t(2) = 11.350, F = 3.550 (SDP = 0.3106), n = 2, c-fos mRNA, P = 0.0207, t(2) = 6.845, F = 1.122 (SDP = 0.4817), n = 2; BDNF stimulation: e4 c-fos pre-mRNA, P = 0.0485, t(2) = 4.373, F = 1.807 (SDP = 0.4868), n = 2, c-fos mRNA, P = 0.0322, t(2) = 5.440, F = 137.97 (SDP = 0.0541), n = 2; e5 c-fos pre-mRNA, P = 0.0489, t(2) = 4.353, F = 17.288 (SDP = 0.1503), n = 2, c-fos mRNA, P = 0.0223, t(2) = 6.582, F = 26.669 (SDP = 0.1218), n = 2 biological replicates ( Fig. 5c) . All unpaired two-tailed t-test. SDP is the P value from comparing the s.d. for both groups. SDP > 0.05 means the two s.d. values are not significantly different and can be used for an unpaired t-test. Figure 6 . c-fos mRNA, Cortex: P = 0.0458, t(4) = 4.511, n = 5 mice, Hippocampus: P = 0.0067, t(5) = 4.455, n = 5 mice, Cerebellum: P = 0.0133, t(4) = 47.767, n = 5 mice; Cortex, c-fos e4, P = 0.0150, t(4) = 4.084, n = 5 mice, c-fos e5, P = 0.034, t(4) = 3.154, n = 5 mice; Hippocampus, c-fos e1, P = 0.0386, t(4) = 3.036, n = 5 mice, c-fos e2, P = 0.0419, t(5) = 2.717, n = 5 mice, c-fos e4, P = 0.0211, t(4) = 3.686, n = 5 mice, c-fos e5, P = 0.0028, t(5) = 5.454, n = 5 mice (Fig. 6a) . c-fos mRNA, visual cortex: P = 0.0069, t(2) = 11.966, n = 3 mice; c-fos e5, P = 0.0485, t(4) = 2.806, n = 3 mice (Fig. 6b) . All unpaired two-tailed t-test with Welch correction. 
